8-K: ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

ZimVie Inc. reported its fourth quarter and full year 2024 financial results, highlighting a transformational year focused on becoming a pure-play dental company and improving its financial profile.

Summary

• ZimVie Inc. reported its financial results for the quarter and year ended December 31, 2024.
• Third party net sales for the full year 2024 were $449.7 million, a decrease of 1.6% on a reported basis and 1.2% in constant currency compared to 2023.
• Net loss for the full year 2024 was $(33.8) million, an improvement of $22.2 million compared to the net loss of $(56.0) million in 2023.
• Adjusted EBITDA for the full year 2024 was $60.0 million, or 13.3% of third party net sales, an increase of $9.2 million compared to 2023.
• The company projects full year 2025 net sales to be between $445 million and $460 million, representing a growth of -1% to 2% on a reported basis and flat to 3% in constant currency.
• Adjusted EBITDA for 2025 is projected to be between $65 million and $70 million, an increase of 8% to 17%.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While sales decreased slightly, the company has made significant progress in reducing debt and improving profitability. The 2025 guidance is cautiously optimistic.

Positives

• ZimVie reduced its net debt by more than $290 million in 2024.
• Adjusted EBITDA margins increased by over 4 percentage points in the fourth quarter of 2024 compared to the fourth quarter of 2023.
• The company streamlined its organization through corporate cost reduction and manufacturing and supply chain efficiency initiatives.
• Net loss improved by $22.2 million year-over-year, from $(56.0) million to $(33.8) million.
• Adjusted net income for the full year 2024 was $17.0 million, an increase of $11.1 million versus the full year 2023.

Negatives

• Third party net sales for the full year 2024 decreased by 1.6% on a reported basis and 1.2% in constant currency compared to 2023.
• The company reported a net loss of $(33.8) million for the full year 2024.
• Fourth quarter net sales decreased by 1.4% on a reported basis and 0.9% in constant currency versus the fourth quarter of 2023.

Risks

• The company's performance is dependent on new product development, technological advances, and innovation.
• Shifts in product category or regional sales mix could impact results.
• Supply and prices of raw materials and products, including impacts from tariffs, pose a risk.
• Pricing pressures from competitors, customers, dental practices, and insurance providers could affect profitability.
• Changes in customer demand due to demographic changes or other factors could impact sales.
• Challenges relating to changes in and compliance with governmental laws and regulations could create difficulties.
• Breaches or failures of information technology systems, including cyberattacks, could disrupt business operations.
• The company's ability to retain independent agents and distributors is crucial.
• The effect of mergers and acquisitions on relationships with customers, suppliers and lenders and on operating results and businesses generally could impact performance.
• Changes in general industry and market conditions, including domestic and international growth rates, could affect the company.
• Changes in general domestic and international economic conditions, including inflation and interest rate and currency exchange rate fluctuations, could impact the company.
• The effects of global pandemics and other adverse public health developments on the global economy, the company's business and operations and the business and operations of its suppliers and customers, including the deferral of elective procedures and the company's ability to collect accounts receivable, could impact the company.

Future Outlook

ZimVie projects net sales for the full year 2025 to be between $445 million and $460 million, representing a growth of -1% to 2% on a reported basis and flat to 3% in constant currency; adjusted EBITDA is projected to be between $65 million and $70 million, an increase of 8% to 17%; and adjusted EPS is projected to be between $0.80 and $0.95, an increase of 29% to 53%.

Management Comments

• 2024 was a transformational year for ZimVie, according to Vafa Jamali, President and Chief Executive Officer.
• The company became a pure play dental company and reshaped its financial profile, reducing net debt by more than $290 million.
• ZimVie streamlined its organization through corporate cost reduction, introduced manufacturing and supply chain efficiency initiatives, and increased Adjusted EBITDA margins by over 4 percentage points in the fourth quarter of 2024 compared to the fourth quarter of 2023 despite a softer end market.
• Management is optimistic about the long-term drivers of the dental implant market, supported by the continued success of training and education programs in 2024.
• ZimVie is well positioned to take advantage of the growth in the dental implant and digital solutions market for 2025 and beyond.

Industry Context

ZimVie's focus on the dental market and its efforts to streamline operations and reduce debt align with broader industry trends of specialization and efficiency improvements. The company's emphasis on digital solutions and training programs reflects the increasing importance of technology and education in the dental implant sector.

Comparison to Industry Standards

• Comparing ZimVie's performance to industry leaders like Straumann and Danaher's dental segment, it is clear that ZimVie is in a period of transition, focusing on streamlining and debt reduction.
• Straumann, for example, consistently reports organic revenue growth in the high single digits or low double digits, while ZimVie is projecting a more modest growth for 2025.
• However, ZimVie's focus on improving EBITDA margins and reducing debt is a positive sign, as these metrics are closely watched by investors in the medical device industry.
• Companies like Dentsply Sirona are also undergoing transformations, with a focus on innovation and efficiency, providing a relevant benchmark for ZimVie's progress.

Stakeholder Impact

• Shareholders will likely view the debt reduction and margin improvement positively.
• Employees may experience further restructuring as the company streamlines operations.
• Customers can expect continued investment in new products and digital solutions.
• Suppliers may face pressure to reduce costs as the company focuses on efficiency.
• Creditors benefit from the reduced debt and improved financial stability.

Next Steps

• Management will host a conference call on February 26, 2025, to discuss the fourth quarter and full year 2024 financial results.
• The company will continue to focus on expanding portfolio adoption, reducing expenses, and driving operating efficiency in 2025.

Key Dates